Edition:
United Kingdom

NanoString Technologies Inc (NSTG.OQ)

NSTG.OQ on NASDAQ Stock Exchange Global Market

8.42USD
4:10pm GMT
Change (% chg)

$-0.05 (-0.59%)
Prev Close
$8.47
Open
$8.42
Day's High
$8.47
Day's Low
$8.32
Volume
9,744
Avg. Vol
67,801
52-wk High
$20.67
52-wk Low
$7.03

Chart for

About

NanoString Technologies, Inc. develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling... (more)

Overall

Beta: 1.06
Market Cap(Mil.): $407.81
Shares Outstanding(Mil.): 25.20
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.27 16.62
EPS (TTM): -- -- --
ROI: -- 13.90 10.61
ROE: -- 16.71 14.21

BRIEF-Nanostring Appoints Thomas Bailey As CFO

* NANOSTRING APPOINTS THOMAS BAILEY AS CHIEF FINANCIAL OFFICER

16 Jan 2018

BRIEF-Nanostring Technologies Signs Sales Agreement With Cowen And Co

* NANOSTRING TECHNOLOGIES SIGNS SALES AGREEMENT WITH COWEN AND CO RELATING TO COMMON STOCK OFFERING OF UP TO $40 MILLION - SEC FILING Source text (http://bit.ly/2CPZkbR) Further company coverage:

08 Jan 2018

BRIEF-NanoString And RikenGenesis Announce Partnership To Commercialize Ncounter-Based Diagnostic Assays In Japan

* NANOSTRING AND RIKENGENESIS ANNOUNCE PARTNERSHIP TO COMMERCIALIZE NCOUNTER-BASED DIAGNOSTIC ASSAYS IN JAPAN

04 Jan 2018

BRIEF-Nanostring Technologies reports Q3 loss per share $0.45

* Nanostring Technologies Inc releases operating results for third quarter of 2017

02 Nov 2017

BRIEF-‍Nanostring and NSABP Foundation enter into agreement to study immunophenotypes in colorectal cancer​

* ‍Nanostring and NSABP foundation enter into agreement to study immunophenotypes in colorectal cancer​ Source text for Eikon: Further company coverage:

26 Oct 2017

BRIEF-NanoString Technologies Inc files for mixed shelf of up to $100 million - SEC filing ‍​

* NanoString Technologies Inc files for mixed shelf of up to $100 million - SEC filing ‍​ Source text: [http://bit.ly/2iIzVbn] Further company coverage:

30 Aug 2017

BRIEF-NanoString Technologies Q2 loss per share $0.20

* NanoString Technologies releases operating results for second quarter of 2017

08 Aug 2017

BRIEF-Nanostring Technologies signs‍ collaboration agreement with Lam Research

* Nanostring technologies- co, ‍ lam research announced collaboration to develop nanostring's proprietary hyb & seq next generation sequencing platform​

08 Aug 2017

BRIEF-Nanostring Technologies Inc says co entered into collaboration agreement with Lam Research Corporation- SEC Filing

* Nanostring Technologies Inc - on August 4, 2017, Nanostring Technologies, Inc. entered into collaboration agreement with lam research corporation

08 Aug 2017

Competitors

Earnings vs. Estimates